☆ 4.8 Article

EASL Clinical Practice Guidelines on the management of benign liver tumours

JOURNAL OF HEPATOLOGY (2016)

Get Full Text
Add to Collection

Journal

JOURNAL OF HEPATOLOGY
Volume 65, Issue 2, Pages 386-398

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jhep.2016.04.001

Keywords

-

Categories

Gastroenterology & Hepatology

Funding

  1. BMS
  2. Gilead Science
  3. IntegraGen
  4. Merck
  5. Roche
  6. Novartis
  7. Bayer
  8. Tibotec
  9. Vertex
  10. Janssen Cilag
  11. Achillion
  12. Lundbeck
  13. GSK
  14. GenSpera
  15. Abbve
  16. AlfaWasserman
  17. Jannerex
  18. Janssen and Sanofi
  19. Astellas
  20. Celgene
  21. Blueprint and Pfizer

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.